Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SRI and Taiho to develop new approach to breast cancer

Oct. 25, 1996

NIH seeks licensees for dual topoisomerase/tubulin polymerization inhibitor

Oct. 25, 1996

Enzon selects Medac as marketing partner for Oncaspar

Oct. 25, 1996

Isis antisense compound and analogues covered by U.S. patent

Oct. 18, 1996

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Oct. 18, 1996

Natural antitumor indanone reported by Sagami

Oct. 18, 1996

Eisai claims RXR agonists

Oct. 18, 1996

New antitumor agents from Sagami

Oct. 18, 1996

VCAM-1 inhibitors from Sagami

Oct. 18, 1996

Banyu reports natural antitumor agent

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...